Waypoint Orthopedics Submits 510(k) Application for Waypoint GPS™

MALVERN, Pa., July 15, 2022 (GLOBE NEWSWIRE) — Waypoint Orthopedics, Inc., a spinal instrumentation company, announced the company’s recent submission of an FDA 510(k) application for the Waypoint GPS™ – a smart bone awl for use during pedicle screw pilot hole drilling. The system is designed to provide the surgeon visual feedback that indicates a change in color at the tip of the probe and may indicate contact of the tip with soft tissues and possible vertebral cortex perforation. The Waypoint GPS™ is indicated for use in both open and percutaneous (MIS) surgical approaches to the spine.

The Waypoint GPS is a Smart Gear Shift™ that looks, feels, and acts like a standard bone awl, while providing the operator with additional information via visual feedback. It utilizes proprietary color-sensing technology displayed wirelessly to an app-based operating system in real-time – potentially making vertebral fixation safer and more efficient for everyone in the operating room.

“The Waypoint Orthopedics team has worked tirelessly over the last 18 months to develop and test the Waypoint GPS, in anticipation of this submission. I am incredibly proud of all the hard work,” said Jeffrey F. O’Donnell, Jr., President and CEO of Waypoint Orthopedics. “We are excited to work with the FDA in bringing this much-needed tool to the operating room, enhancing the surgeon’s confidence during the cannulation of each pedicle, while potentially reducing the amount of ionizing radiation during a case. We believe in surgeon designed products, and have had tremendous input and guidance from our world-class Surgeon Advisory Board throughout this process.” 

Waypoint Orthopedics, a Runway Healthcare LP portfolio company, will look to transfer its technology to a commercial entity upon approval from the FDA, which is anticipated later this year.

About Waypoint Orthopedics:

Waypoint Orthopedics, Inc. was founded to make vertebral fixation safer and more efficient for the patient, surgeon, and support staff. Waypoint Orthopedics’ controlling stockholder is Runway Healthcare, LP – a MedTech accelerator fund.

Inquiries: |

About Runway Healthcare Partners, LLC:

Runway Healthcare is an early-stage MedTech Accelerator. Runway finances and manages the product development process of all portfolio companies. After navigating the company through the regulatory process, Runway transitions the company’s ownership to larger multi-national healthcare companies for commercialization. Runway Healthcare is focused on early-stage technology in the Orthopedic, Cardiovascular, and Neurology sectors.

Inquires: |

Forward-Looking Statement:

This press release contains “forward-looking statements” concerning the development of Waypoint Orthopedics products, the potential benefits and attributes of those products, and the company’s expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions, and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. Waypoint Orthopedics undertakes no obligation to update any forward-looking statements for any reason.

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button